These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 20418469)

  • 21. Immunohistochemical detection of proliferating cell nuclear antigen and Ki-67 in mast cell tumors from dogs.
    Abadie JJ; Amardeilh MA; Delverdier ME
    J Am Vet Med Assoc; 1999 Dec; 215(11):1629-34. PubMed ID: 14567425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutations in the fifth immunoglobulin-like domain of kit are common and potentially sensitive to imatinib mesylate in feline mast cell tumours.
    Isotani M; Yamada O; Lachowicz JL; Tamura K; Yagihara H; Fujino Y; Ono K; Washizu T; Bonkobara M
    Br J Haematol; 2010 Jan; 148(1):144-53. PubMed ID: 19804453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of proto-oncogene C-kit and correlation with morphological evaluations in canine cutaneous mast cell tumors.
    Passantino L; Passantino G; Cianciotta A; Ribaud MR; Lo Presti G; Ranieri G; Perillo A
    Immunopharmacol Immunotoxicol; 2008; 30(3):609-21. PubMed ID: 18608529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical expression of Ki67, c-erbB-2, and c-kit antigens in benign and malignant pheochromocytoma.
    Tavangar SM; Shojaee A; Moradi Tabriz H; Haghpanah V; Larijani B; Heshmat R; Lashkari A; Azimi S
    Pathol Res Pract; 2010 May; 206(5):305-9. PubMed ID: 20189725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary melanoma of the skin and cutaneous melanomatous metastases: comparative histologic features and immunophenotypes.
    Guerriere-Kovach PM; Hunt EL; Patterson JW; Glembocki DJ; English JC; Wick MR
    Am J Clin Pathol; 2004 Jul; 122(1):70-7. PubMed ID: 15272532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Principles of treatment for mast cell tumors.
    Govier SM
    Clin Tech Small Anim Pract; 2003 May; 18(2):103-6. PubMed ID: 12831070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implications of prognostic markers in brain tumors.
    Grzybicki DM; Moore SA
    Clin Lab Med; 1999 Dec; 19(4):833-47. PubMed ID: 10572718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic analysis of rectal stromal tumors by reference of National Institutes of Health risk categories and immunohistochemical studies.
    Tsai MC; Lin JW; Lin SE; Chen HH; Lee CM; Hu TH
    Dis Colon Rectum; 2008 Oct; 51(10):1535-43. PubMed ID: 18633679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. KI-67 AND hTERT expression can aid in the distinction between malignant and benign pheochromocytoma and paraganglioma.
    Elder EE; Xu D; Höög A; Enberg U; Hou M; Pisa P; Gruber A; Larsson C; Bäckdahl M
    Mod Pathol; 2003 Mar; 16(3):246-55. PubMed ID: 12640105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intranasal mast cell tumors: Clinical, immunohistochemical, and molecular features in 20 dogs.
    Larsen E; Watson AM; Muñoz Gutiérrez JF
    Vet Pathol; 2022 Nov; 59(6):915-921. PubMed ID: 35787192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Feline cutaneous nerve sheath tumours: histological features and immunohistochemical evaluations.
    Mandara MT; Fabriani E; Pavone S; Pumarola M
    Res Vet Sci; 2013 Oct; 95(2):548-55. PubMed ID: 23659741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical assessment of proliferative activity in adrenocortical neoplasms.
    Goldblum JR; Shannon R; Kaldjian EP; Thiny M; Davenport R; Thompson N; Lloyd RV
    Mod Pathol; 1993 Nov; 6(6):663-8. PubMed ID: 7508113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bax/bcl-2: cellular modulator of apoptosis in feline skin and basal cell tumours.
    Madewell BR; Gandour-Edwards R; Edwards BF; Matthews KR; Griffey SM
    J Comp Pathol; 2001; 124(2-3):115-21. PubMed ID: 11222007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histopathology and biologic behavior of pleomorphic cutaneous mast cell tumors in fifteen cats.
    Johnson TO; Schulman FY; Lipscomb TP; Yantis LD
    Vet Pathol; 2002 Jul; 39(4):452-7. PubMed ID: 12126148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell proliferation in feline normal, hyperplastic and neoplastic mammary tissue--an immunohistochemical study.
    Dias Pereira P; Carvalheira J; Gärtner F
    Vet J; 2004 Sep; 168(2):180-5. PubMed ID: 15301767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An immunohistochemical study of vitamin D receptor expression in canine cutaneous mast cell tumours.
    Russell DS; Rassnick KM; Erb HN; Vaughan MM; McDonough SP
    J Comp Pathol; 2010; 143(2-3):223-6. PubMed ID: 20334872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A retrospective study of eyelid tumors from 43 cats.
    Newkirk KM; Rohrbach BW
    Vet Pathol; 2009 Sep; 46(5):916-27. PubMed ID: 19429997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Telomerase activity as prognostic factor in gastrointestinal stromal tumors of the stomach.
    Kawai J; Kodera Y; Fujiwara M; Kasai Y; Nagasaka T; Koike M; Hibi K; Ito K; Akiyama S; Nakao A
    Hepatogastroenterology; 2005; 52(63):959-64. PubMed ID: 15966241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. All subunits of the interleukin-2 receptor are expressed by canine cutaneous mast cell tumours.
    Meyer A; Gruber AD; Klopfleisch R
    J Comp Pathol; 2013 Jul; 149(1):19-29. PubMed ID: 23276382
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lomustine for treatment of mast cell tumors in cats: 38 cases (1999-2005).
    Rassnick KM; Williams LE; Kristal O; Al-Sarraf R; Baez JL; Zwahlen CH; Dank G
    J Am Vet Med Assoc; 2008 Apr; 232(8):1200-5. PubMed ID: 18412534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.